The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s ulcerative colitis market report forecasts the ulcerative colitis market size to grow to $8.86 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Ulcerative Colitis Market Report 2023 – https://www.thebusinessresearchcompany.com/report/ulcerative-colitis-global-market-report

Ulcerative Colitis Market Size Forecast
The global ulcerative colitis market is expected to grow from $6.35 billion in 2022 to $6.84 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global ulcerative colitis market size is expected to reach $8.86 billion in 2027 at a CAGR of 6.7%.

North America held the largest ulcerative colitis market share.

Key Ulcerative Colitis Market Driver ­– Increase In Healthcare Expenditure
For example, according to the 2021-2030 National Health Expenditure (NHE) report published in March 2022 by the Centres for Medicare & Medicaid Services, a US-based Department of Health and Human Services department, the annual increase in national health spending was predicted to average 5.1% between 2021 and 2030, reaching $6.8 trillion by 2030. Furthermore, Medicare spending is predicted to grow at a 7.2% annual rate from 2021 to 2030, while Medicaid spending is expected to grow at a 5.6% yearly rate. As a result, rising healthcare costs are propelling the ulcerative colitis industry forward.

Request for A Sample Of The Global Ulcerative Colitis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10328&type=smp

Key Ulcerative Colitis Market Trend – Technological Advancement
Companies in the ulcerative colitis industry are embracing new technology in order to maintain their market position. Clario ERT Inc., a US-based healthcare research and technology firm, and GI Reviewers LLC, a US-based pharmaceutical reviews and assessment organisation, along with RSIP Vision, an ISRAEL-based software company, for example, released their innovative and human-level AI technology-based rating system in March 2023 to improve the efficiency and consistency of inflammatory bowel disease (IBD) scoring, such as ulcerative colitis (UC) and Crohn’s disease scoring. The technology is expected to improve the repeatability of colonoscopy video scoring, expedite workflow by reducing the time required for a human expert reader to score, and, eventually, increase recruitment and reduce clinical trial costs. The performance of algorithms was found to be equivalent to that of human reviewers using the Kappa metric technology. The system was trained on hundreds of films from various sites and devices, totaling over 100,000 pictures, all of which were evaluated by a gastroenterology expert.

Ulcerative Colitis Market Segment
1) By Drug Type: Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, Other Drug Types
2) By Disease Type: Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis
3) By Molecule Type: Biologics, Small Molecules
4) By Route of Administration: Oral, Injectables
5) By End-User: Hospital Pharmacies, Retail Pharmacies, Drug Store, Other End-User

Ulcerative Colitis Market Major Players and Strategies
Major players in the ulcerative colitis market are Abbott Laboratories, AbbVie Inc., Ajinomoto Co. Inc., AstraZeneca PLC, Bausch Health Companies Inc., Eli-Lilly And Co., Johnson & Johnson, Index Pharmaceuticals Holdings AB, GlaxoSmithKline PLC, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Allergan PLC, Bayer AG, BioLineRx Ltd., and Celgene Corporation.

Pfizer Inc., a biopharmaceutical corporation based in the United States, paid about $6.7 billion for Arena Pharmaceuticals Inc. in March 2022. This acquisition seeks to broaden Pfizer’s existing inflammation and immunology pipeline portfolio of pharmaceuticals into the inflammation and immunology therapeutic area, assisting in the goal of developing breakthroughs to enhance the lives of individuals suffering from immuno-inflammatory illnesses. Arena Pharmaceuticals Inc. is a biopharmaceutical firm based in the United States that developed Etrasimod, a highly selective, once-daily oral sphingosine 1-phosphate (S1P) receptor modulator used to treat ulcerative colitis, Crohn’s disease, and other conditions.

The Ulcerative Colitis Global Market Report 2023 covers regional data on ulcerative colitis market size, ulcerative colitis market trends and drivers, opportunities, strategies, and ulcerative colitis market competitor analysis. The countries covered in the ulcerative colitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Ulcerative colitis is a chronic inflammatory bowel disease (IBD) that is classified as an autoimmune disorder in which the immune system destroys healthy tissue in the large intestine, causing inflammation on the large intestine’s surface layer. Diarrhoea, weight loss, abdominal discomfort, anaemia, blood or pus in bowel movements, and other symptoms are included.

View More Reports Related To The Ulcerative Colitis Market –
Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2023
Colonoscopes Global Market Report 2023
Inflammatory Bowel Disease Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: